FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

High Court Nominee Favorable on Preemption Doctrine

The Drug & Device Law blog reviews cases that president Donald Trumps U.S. Supreme Court nominee Neil Gorsuch has decided and determines that he is su...

Federal Register

Unredacted CVs for Advisory Panel Members to be Posted

Federal Register Notice: FDA modifies the process by which it collects and post curricula vitae of advisory committee members.

Medical Devices

FDA Clears Elektas Venezia Applicator for Cervical Cancer

FDA clears an Elekta 510(k) for its Venezia applicator for gynecological brachytherapy for use in treating advanced-stage cervical cancer.

FDA General

Rogue FDA Employees Move to Protect Inspection Info

The rogue FDA employees running an alternative Twitter handle @alt_fda have uploaded to the cloud an archive of inspection citations that date back ...

Medical Devices

AdvaMed Opposes Adding UDI Info on Claims Forms

Medical device lobbying group AdvaMed continues to oppose adding unique device identifier information to insurance claims forms.

FDA General

FDA Posting Unredacted Panel Member CVs

FDA says it is modifying the process on how it collects and posts curricula vitae (CVs) of advisory committee members so that they will be posted to i...

Human Drugs

FDA Issues Complete Response on Combo Pain Drug

FDA issues Charleston Laboratories and Daiichi Sankyo a complete response letter on their NDA for CL-108 (hydrocodone, acetaminophen, promethazine), a...

Human Drugs

House Subcommittee to Discuss Generics Bill

House Energy and Commerce Committee chairman Greg Walden (R-OR) says a yet-to-be-announced health subcommittee hearing next week will take up a bill b...

Biologics

FDA Accepts 2 Merck sBLAs for Keytruda

FDA accepts for review two Merck supplemental BLAs for Keytruda (pembrolizumab), the companys anti-PD-1 therapy in patients with locally advanced or m...

Medical Devices

FDA Permits Marketing of Infant Seeker System

FDA permits the marketing under the de novo process of Baebies Inc.s Seeker System for screening four rare Lysosomal Storage Disorders in newborns.